vs
EURONET WORLDWIDE, INC.（EEFT）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
EURONET WORLDWIDE, INC.的季度营收约是Royalty Pharma plc的1.8倍（$1.1B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 4.7%，领先29.8%），EURONET WORLDWIDE, INC.同比增速更快（5.9% vs 4.8%），过去两年EURONET WORLDWIDE, INC.的营收复合增速更高（13.7% vs 4.6%）
Euronet Worldwide是总部位于美国堪萨斯州利伍德的全球电子支付服务提供商，业务涵盖自动柜员机（ATM）、销售点（POS）服务、信用卡/借记卡服务、货币兑换及其他电子金融服务与支付软件，旗下拥有Transact、PaySpot、epay等多家预付费业务子公司。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
EEFT vs RPRX — 直观对比
营收规模更大
EEFT
是对方的1.8倍
$622.0M
营收增速更快
EEFT
高出1.1%
4.8%
净利率更高
RPRX
高出29.8%
4.7%
两年增速更快
EEFT
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $622.0M |
| 净利润 | $51.8M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 9.1% | 62.4% |
| 净利率 | 4.7% | 34.4% |
| 营收同比 | 5.9% | 4.8% |
| 净利润同比 | 14.3% | 2.9% |
| 每股收益（稀释后） | $0.97 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EEFTRPRX
| Q4 25 | $1.1B | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $1.1B | $578.7M | ||
| Q1 25 | $915.5M | $568.2M | ||
| Q4 24 | $1.0B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $986.2M | $537.3M | ||
| Q1 24 | $857.0M | $568.0M |
净利润EEFTRPRX
| Q4 25 | $51.8M | $214.2M | ||
| Q3 25 | $122.0M | $288.2M | ||
| Q2 25 | $97.6M | $30.2M | ||
| Q1 25 | $38.4M | $238.3M | ||
| Q4 24 | $45.3M | $208.2M | ||
| Q3 24 | $151.5M | $544.0M | ||
| Q2 24 | $83.1M | $102.0M | ||
| Q1 24 | $26.2M | $4.8M |
营业利润率EEFTRPRX
| Q4 25 | 9.1% | 62.4% | ||
| Q3 25 | 17.0% | 70.1% | ||
| Q2 25 | 14.8% | 36.3% | ||
| Q1 25 | 8.2% | 94.0% | ||
| Q4 24 | 11.7% | 60.9% | ||
| Q3 24 | 16.6% | — | ||
| Q2 24 | 13.6% | 50.2% | ||
| Q1 24 | 7.5% | -13.0% |
净利率EEFTRPRX
| Q4 25 | 4.7% | 34.4% | ||
| Q3 25 | 10.6% | 47.3% | ||
| Q2 25 | 9.1% | 5.2% | ||
| Q1 25 | 4.2% | 41.9% | ||
| Q4 24 | 4.3% | 35.1% | ||
| Q3 24 | 13.8% | 96.3% | ||
| Q2 24 | 8.4% | 19.0% | ||
| Q1 24 | 3.1% | 0.8% |
每股收益（稀释后）EEFTRPRX
| Q4 25 | $0.97 | $0.49 | ||
| Q3 25 | $2.75 | $0.67 | ||
| Q2 25 | $2.27 | $0.07 | ||
| Q1 25 | $0.85 | $0.55 | ||
| Q4 24 | $0.96 | $0.46 | ||
| Q3 24 | $3.21 | $1.21 | ||
| Q2 24 | $1.73 | $0.23 | ||
| Q1 24 | $0.55 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $618.7M |
| 总债务越低越好 | $1.0B | $9.0B |
| 股东权益账面价值 | $1.3B | $9.7B |
| 总资产 | $6.5B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.79× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资EEFTRPRX
| Q4 25 | $1.0B | $618.7M | ||
| Q3 25 | $1.2B | $938.9M | ||
| Q2 25 | $1.3B | $631.9M | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | $1.3B | $929.0M | ||
| Q3 24 | $1.5B | $950.1M | ||
| Q2 24 | $1.3B | $1.8B | ||
| Q1 24 | $1.2B | $843.0M |
总债务EEFTRPRX
| Q4 25 | $1.0B | $9.0B | ||
| Q3 25 | $1.1B | $8.9B | ||
| Q2 25 | $1.0B | $8.0B | ||
| Q1 25 | $1.9B | $7.6B | ||
| Q4 24 | $1.1B | $7.6B | ||
| Q3 24 | $1.2B | $7.6B | ||
| Q2 24 | $1.0B | $7.6B | ||
| Q1 24 | $1.3B | $6.1B |
股东权益EEFTRPRX
| Q4 25 | $1.3B | $9.7B | ||
| Q3 25 | $1.3B | $9.6B | ||
| Q2 25 | $1.4B | $9.5B | ||
| Q1 25 | $1.3B | $9.8B | ||
| Q4 24 | $1.2B | $10.3B | ||
| Q3 24 | $1.4B | $10.3B | ||
| Q2 24 | $1.2B | $9.8B | ||
| Q1 24 | $1.2B | $9.9B |
总资产EEFTRPRX
| Q4 25 | $6.5B | $19.6B | ||
| Q3 25 | $6.3B | $19.3B | ||
| Q2 25 | $6.6B | $18.3B | ||
| Q1 25 | $6.1B | $17.6B | ||
| Q4 24 | $5.8B | $18.2B | ||
| Q3 24 | $6.3B | $18.0B | ||
| Q2 24 | $6.1B | $17.7B | ||
| Q1 24 | $5.7B | $16.1B |
负债/权益比EEFTRPRX
| Q4 25 | 0.79× | 0.92× | ||
| Q3 25 | 0.85× | 0.93× | ||
| Q2 25 | 0.74× | 0.84× | ||
| Q1 25 | 1.46× | 0.78× | ||
| Q4 24 | 0.92× | 0.74× | ||
| Q3 24 | 0.88× | 0.74× | ||
| Q2 24 | 0.85× | 0.78× | ||
| Q1 24 | 1.01× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $559.8M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $434.3M | — |
| 自由现金流率自由现金流/营收 | 39.2% | — |
| 资本支出强度资本支出/营收 | 11.3% | — |
| 现金转化率经营现金流/净利润 | 10.81× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $722.3M | — |
8季度趋势，按日历期对齐
经营现金流EEFTRPRX
| Q4 25 | $559.8M | $827.1M | ||
| Q3 25 | $197.3M | $702.6M | ||
| Q2 25 | $182.9M | $364.0M | ||
| Q1 25 | $1.7M | $596.1M | ||
| Q4 24 | $732.8M | $742.5M | ||
| Q3 24 | $440.3M | $703.6M | ||
| Q2 24 | $182.2M | $658.2M | ||
| Q1 24 | $30.0M | $664.6M |
自由现金流EEFTRPRX
| Q4 25 | $434.3M | — | ||
| Q3 25 | $161.2M | — | ||
| Q2 25 | $148.3M | — | ||
| Q1 25 | $-21.5M | — | ||
| Q4 24 | $615.6M | — | ||
| Q3 24 | $414.5M | — | ||
| Q2 24 | $148.8M | — | ||
| Q1 24 | $6.2M | — |
自由现金流率EEFTRPRX
| Q4 25 | 39.2% | — | ||
| Q3 25 | 14.1% | — | ||
| Q2 25 | 13.8% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 58.8% | — | ||
| Q3 24 | 37.7% | — | ||
| Q2 24 | 15.1% | — | ||
| Q1 24 | 0.7% | — |
资本支出强度EEFTRPRX
| Q4 25 | 11.3% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 2.8% | — |
现金转化率EEFTRPRX
| Q4 25 | 10.81× | 3.86× | ||
| Q3 25 | 1.62× | 2.44× | ||
| Q2 25 | 1.87× | 12.06× | ||
| Q1 25 | 0.04× | 2.50× | ||
| Q4 24 | 16.18× | 3.57× | ||
| Q3 24 | 2.91× | 1.29× | ||
| Q2 24 | 2.19× | 6.45× | ||
| Q1 24 | 1.15× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EEFT
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
